Journal of Antibiotics p. 676 - 682 (1995)
Update date:2022-09-26
Topics:
Paris
Francois
Molherat
Albano
Robin
Vuilhorgne
Barriere
Pristinamycin I(A) was modified in a two-step procedure to give original derivatives possessing a tricyclic nucleus (8a, 8b, 8c) or a substituted pyrrole ring (10a, 10b) in place of the natural exocyclic 3-hydroxy-picolinoyl residue. This transformation involved firstly preparation of pyridinium betaines 5 from pristinamycin I(A) and secondly a 1~3 dipolar cycloaddition between 5 and N-substituted maleimides or diethyl acetylenedicarboxylate. The compounds obtained were evaluated as antibacterial agents alone and in association with pristinamycin II(A).
View MoreHangzhou Kai Peng Biotechnology Co., Ltd.
Contact:86-571-89939007
Address:NO. 499, Wensan West Road, Xihu District, Hangzhou, 310012, China
Contact:0086 371 65711996
Address:Jalan 4/3, Kawasan Perindustrian Serendah, 48000 Rawang,
Contact:+86-717-6370352
Address:168 Chengdong Avenue, Yichang, Hubei 443003, P. R.China
Shanghai Kefu Chemical Co.,Ltd.
Contact:+86-21-34616196
Address:Room601-602, Xuhui Business Building, No.168, Yude Road, Shanghai
Anhui Biochem United Pharmaceutical Co., Ltd.
Contact:0086 551 5167062 / 5228268
Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
Doi:10.1039/DT9950003691
(1995)Doi:10.1021/om950457v
(1996)Doi:10.1080/17415993.2013.765429
(2013)Doi:10.1016/S0040-4039(00)76955-3
(1994)Doi:10.1016/0040-4039(95)02019-L
(1995)Doi:10.1016/S0040-4020(01)92099-X
(1981)